Clinical Trials

Discover findings from NEI-funded research suggesting that low macular pigment density may serve as an early warning sign of glaucoma.

Discover how autonomous artificial intelligence (AI) diabetic eye exams improve completion rates for screenings aimed at preventing diabetes eye diseases in children and youth.

Learn about a new analysis uncovering three gene variants associated with glaucoma susceptibility in individuals of African ancestry. These findings shed light on potential genetic factors contributing to the disproportionate impact of glaucoma on this population.

Discover how a groundbreaking study combines retinal imaging, genetics, and big data to estimate an individual's risk of developing eye and systemic diseases.

University of Houston optometry researcher cautions against the use of low-level red light therapy for myopia treatment, citing potential risks to retinal health.

Researchers at Indiana University School of Optometry uncover varying risks of retinal damage from diabetes across ethnic groups, with African Americans and Asians, particularly males, at higher risk.

New research from Oregon Health & Science University unveils an AI technology capable of accurately detecting all severe cases of retinopathy of prematurity (ROP), offering potential for widespread screening and sight-saving treatment. Published in JAMA Ophthalmology.

Discover groundbreaking findings from a National Eye Institute-backed study revealing that infants fixate on meaningful regions in photos akin to adults, offering insights into early visual development and potential applications for detecting brain-based vision issues.

Discover how modifier genes influence the progression of RP59, a type of retinitis pigmentosa, as researchers uncover the impact of the ALG6 variant on retinal health. Insights from a study conducted at the University of Alabama at Birmingham shed light on complex genetic interactions.